Innovating Evaluation and Treatment of Intrapartum Fevers: Where Do We Go from Here?

Autor:	Wilkie GL; Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Obstetrics and Gynecology, University of Massachusetts Medical School, University of Massachusetts Memorial Medical Center, Worcester, Massachusetts., James K; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Ona S; Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Easter SR; Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Chou J; Department of Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Roberts D; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Sahin ZO; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Tuomala R; Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Diouf K; Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Riley L; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York City, New York., Prabhu M; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York City, New York.
Jazyk:	angličtina
Zdroj:	American journal of perinatology [Am J Perinatol] 2023 Feb; Vol. 40 (3), pp. 250-254. Date of Electronic Publication: 2021 Apr 20.
DOI:	10.1055/s-0041-1727279
Abstrakt:	As intrapartum fevers are not always infectious in origin, determining whether antibiotics are indicated is challenging. We previously sought to create a point-of-care calculator using clinical data available at the time of an intrapartum fever to identify the subset of women who require antibiotic treatment to avoid maternal and neonatal morbidity. Despite the use of a comprehensive dataset from our institutions, we were unable to propose a valid and highly predictive model. In this commentary, we discuss why our model failed, as well as future research directions to identify and treat true intraamniotic infection. Developing a risk-stratification model is paramount to minimizing maternal and neonatal exposure to unnecessary antibiotics while allowing for early identification of women and babies at risk for infectious morbidity. KEY POINTS: · Determining whether antibiotics are indicated in intrapartum fever is challenging.. · Developing a risk-stratification model for febrile laboring women is critical to decreasing harm.. · A point-of-care calculator based on clinical and biomarker data is the necessary approach.. Competing Interests: None declared. (Thieme. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu